loteprednol etabonate 0.5 % Ophthalmic Gel
- RxCUI
- 1312625
- RxNorm name
- loteprednol etabonate 0.5 % Ophthalmic Gel
- Display name
- loteprednol etabonate 0.5 % Ophthalmic Gel
- Full name
- loteprednol etabonate 0.5 % Ophthalmic Gel
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loteprednol Etabonate | LOTEPREDNOL ETABONATE | Sentiss Pharmaceuticals LLC | 1fb8140b-c5a3-40eb-8429-2e570921917b | 2026-04-15 | Warnings, Adverse reactions | 1312625 |
| Loteprednol Etabonate | LOTEPREDNOL ETABONATE | Bausch & Lomb Americas Inc. | cc8638ae-0444-4a8b-bcad-fa946f607b5d | 2025-02-04 | Warnings, Adverse reactions | 1312625 |
| LOTEMAX | LOTEPREDNOL ETABONATE | Bausch & Lomb Incorporated | 9a666065-d467-42b8-8ecd-0ec1de9986d5 | 2024-10-24 | Warnings, Adverse reactions | 1312625 |
| Loteprednol Etabonate | LOTEPREDNOL ETABONATE | ARMAS PHARMACEUTICALS INC. | 091a068f-f9b0-b02b-e063-6294a90a95e6 | 2023-10-25 | Warnings, Adverse reactions | 1312625 |
| Loteprednol Etabonate | LOTEPREDNOL ETABONATE | Bausch & Lomb Incorporated | 7bbdbd31-5a8f-4d69-aa8e-5b700895e804 | 2021-03-31 | Warnings, Adverse reactions | 1312625 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9a666065-d467-42b8-8ecd-0ec1de9986d5 | loteprednol etabonate 0.5 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [SCD] · loteprednol etabonate 0.5 % Ophthalmic Gel [SY] | 3 | 12 | These highlights do not include all the information needed to use LOTEMAX safely and effectively. See full prescribing information for LOTEMAX. LOTEMAX ® (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | 20241024 |
| cc8638ae-0444-4a8b-bcad-fa946f607b5d | loteprednol etabonate 0.5 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [SCD] · loteprednol etabonate 0.5 % Ophthalmic Gel [SY] | 3 | 5 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE OPHTHALMIC GEL, for topical ophthalmic use Initial U.S. Approval: 1998 | 20250204 |
| 1fb8140b-c5a3-40eb-8429-2e570921917b | loteprednol etabonate 0.5 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [SCD] · loteprednol etabonate 0.5 % Ophthalmic Gel [SY] | 3 | 2 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE ophthalmic gel, for topical ophthalmic use Initial U.S. Approval: 1998 | 20260415 |
| 7bbdbd31-5a8f-4d69-aa8e-5b700895e804 | loteprednol etabonate 0.5 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [SCD] · loteprednol etabonate 0.5 % Ophthalmic Gel [SY] | 3 | 2 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE OPHTHALMIC GEL 0.5%, for topical ophthalmic use. Initial U.S. Approval: 1998 | 20210331 |
| 091a068f-f9b0-b02b-e063-6294a90a95e6 | loteprednol etabonate 0.5 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [SCD] · loteprednol etabonate 0.5 % Ophthalmic Gel [SY] | 3 | 1 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE ophthalmic gel, for topical ophthalmic use Initial U.S. Approval: 1998 | 20231025 |